SION
Sionna Therapeutics, Inc. Common Stock
NASDAQ: SION · HEALTHCARE · BIOTECHNOLOGY
$45.95
+3.89% today
Updated 2026-05-11
Market cap
$1.96B
P/E ratio
—
P/S ratio
—
EPS (TTM)
$-1.88
Dividend yield
—
52W range
$12 – $46
Volume
0.4M
Sionna Therapeutics, Inc. Common Stock (SION) Financial statements
SEC filings — annual and quarterly data.
Income statement — annual
| Item | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|
| Revenue | $0.00 | $0.00 | $0.00 | $0.00 |
| Revenue growth (YoY) | — | — | — | — |
| Cost of revenue | — | — | $668000.00 | $647000.00 |
| Gross profit | — | — | $-668000.00 | $-647000.00 |
| Gross margin | — | — | — | — |
| R&D | $34.60M | $40.63M | $57.29M | $60.26M |
| SG&A | $6.77M | $9.71M | $13.27M | $28.72M |
| Operating income | $-41.37M | $-50.33M | $-70.56M | $-88.98M |
| Operating margin | — | — | — | — |
| EBITDA | $-41.25M | $-49.75M | $-69.89M | $-88.33M |
| EBITDA margin | — | — | — | — |
| EBIT | $-41.37M | $-50.33M | $-70.56M | $-88.98M |
| Interest expense | — | — | — | — |
| Income tax | — | — | — | — |
| Effective tax rate | 0.0% | 0.0% | 0.0% | 0.0% |
| Net income | $-40.24M | $-47.26M | $-61.69M | $-75.27M |
| Net income growth (YoY) | — | -17.5% | -30.5% | -22.0% |
| Profit margin | — | — | — | — |